Silvia Jurišová

Circulating Tumor Cells With Epithelial–to–mesenchymal Transition Phenotypes Associated With Inferior Outcomes in Primary Breast Cancer

Michal Mego, Marián Karaba, Gabriel Minárik et al. · Anticancer Research · 2019 · 57 citations · Full text

Medicine, Cancer Biology, Oncology +17

Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer

Svetlana Miklikova, Gabriel Minárik, Tatiana Sedláčková et al. · Cancers · 2020 · 32 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Randomized double-blind, placebo-controlled multicenter phase III study of prevention of irinotecan-induced diarrhea by a probiotic mixture containing Bifidobacterium BB-12®Lactobacillus rhamnosus LGG® in colorectal cancer patients

Michal Mego, Radoslav Danis, Jozef Chovanec et al. · Frontiers in Oncology · 2023 · 17 citations · Full text

Medicine, Oncology, Pharmacology +13

Relationship Between Circulating Tumor Cells and Annexin A2 in Early Breast Cancer Patients

Branislav Bystrický, Zuzana Čierna, Gabriela Sieberova et al. · Anticancer Research · 2017 · 11 citations · Full text

Medicine, Cell Biology, Oncology +14

The beneficial effect of probiotics in the prevention of irinotecan-induced diarrhea in colorectal cancer patients with colostomy: a pooled analysis of two probiotic trials (Probio-SK-003 and Probio-SK-005) led by Slovak Cooperative Oncology Group

Michal Mego, Barbora Judita Kasperová, Jozef Chovanec et al. · Frontiers in Oncology · 2024 · 10 citations · Full text

Medicine, Oncology, Pharmacology +15